14 research outputs found
B Cells Compartment in Centenarian Offspring and Old People
Immunosenescence is considered a major contributory factor to the increased frequency of morbidity and mortality among
elderly. On the other hand centenarians are considered the best example of successful ageing. To gain insight into mechanisms of
immunosenescence and its clinical relevance, a possible model is represented by centenarians and/or their offspring. Nowadays
centenarians are not more a curiosity, but in Europe are 1/8000 inhabitants and it has been demonstrated that the centenarian offspring,
who are typically in their 70s and 80s, have a survival advantage when compared with age-matched controls whose parents died at an
average life expectancy. Then again, studies on immunosenescence focus mainly on T cell impairment, although B cells are also affected.
So, in the present preliminary report, we have studied B cell compartment in two classes of individuals, old people and centenarian
offspring. B cell compartment was analysed using anti-IgD and CD27 antibodies which characterize naïve B cells (IgD+ CD27-), memory
unswitched B cells (IgD+CD27+), memory switched B cells(IgD-CD27+) and double negative B cells (DN) (IgD-CD27-), i.e. exhausted
memory cells. As expected, in both cohorts we observed a decreased B cell count. However, in centenarian offspring, naïve B cells are
more abundant whereas exhausted memory cells (DN B cells, IgD-CD27-) do not show the increase that we have previously demonstrated
in healthy elderly donors. These data are similar to that found in previously experiments on young subjects. So, our preliminary results
show that centenarian offspring do not have the typical trend of memory/naive B cell subsets observed in elderly people and this is in
agreement with the higher levels of IgM in the serum of centenarian offspring in comparison with data obtained in age-matched controls.
This reservoir of naive B cell might be one of the causes that make centenarian offspring able to keep fighting off new infections, hence
prolonging their life. So, B cell subset changes could represent a hallmark of successful or unsuccessful ageing and could be used as a
biomarker of human life span, potentially useful for the evaluation of anti-ageing treatment
A double-negative (IgD CD27 ) B cell population is increased in the peripheral blood of elderly people
The T cell branch of the immune system has been extensively studied in the elderly and it is known that
the elderly have impaired immune function, mainly due to the chronic antigenic load that ultimately
causes shrinkage of the T cell repertoire and filling of the immunologic space with memory T cells. In the
present paper,we describe the IgD CD27 double-negative B cell population which (aswe have recently
described) is higher in the elderly. Most of these cells were IgG+. Evaluation of the telomere length and
expression of the ABCB1 transporter and anti-apoptotic molecule, Bcl2, shows that they have the
markers of memory B cells. We also show that these cells do not act as antigen presenting cells, as
indicated by the low levels of CD80 and DR, nor do they express significant levels of the CD40 molecule
necessary to interact with T lymphocytes through the ligand, CD154. Hence, we hypothesize that these
expanded cells are late memory or exhausted cells that have down-modulated the expression of CD27
and filled the immunologic space in the elderly. These cells might be the age-related manifestation of
time-enduring stimulation or dysregulation of the immune system
Biomarkers of aging
Aging is a complex process that negatively impacts the development of the different systems and its ability to function. Moreover, the Aging rate in humans is not the same, principally due to genetic heterogeneity and environmental factors. The aging rate is measured as the decline of functional capacity and stress resistance. Therefore, several attempts have been made to analyse the individual age, ( so-called biological age) compared to chronological age. The biomarkers of aging are age-related body function or composition, these markers aim to assess the biological age and predict the onset of age-related diseases and/or residual lifetime. Such biomarkers should help in one hand to characterise the biological age and on the other hand to identify individuals at high risk of developing age-associated diseases or disabilities. Unfortunately, most of the markers under discussion are related to age-related diseases rather than to age, so none of these markers discussed in literature is a true biomarker of aging. Hence, we discuss some disease-related biomarkers useful for a better understanding of aging and the development of new strategies to counteract it, essential for improving the quality of life of the elderly population
Systemic Immune Responses in Alzheimer’s Disease: In Vitro Mononuclear Cell Activation and Cytokine Production
To investigate the systemic signs of immune-inflammatory responses in Alzheimer’s disease (AD), in the present study
we have analyzed blood lymphocyte subsets and the expression of activation markers on peripheral blood mononuclear cells
(PBMCs) fromADpatients and age-matched healthy controls (HC) activated in vitro by recombinant amyloid-β peptide (rAβ42).
Our study of AD lymphocyte subpopulations confirms the already described decrease of the absolute number and percentage of
B cells when compared to HC lymphocytes, whereas the other subsets are not significantly different in patients and controls.
We report the increased expression of the activation marker CD69 and of the chemokine receptors CCR2 and CCR5 on T cells
but no changes of CD25 after activation. B cells are also activated by rAβ42 as demonstrated by the enhanced expression of
CCR5. Moreover, rAβ42 induces an increased expression of the scavenger receptor CD36 on monocytes. Some activation
markers and chemokine receptors are overexpressed in unstimulated AD cells when compared to controls. This is evidence of
the pro-inflammatory status of AD. Stimulation by rAβ42 also induces the production of the pro-inflammatory cytokines IL-1β,
IL-6, IFN-γ, and TNF-α, and of the anti-inflammatory cytokines IL-10 and IL-1Ra. The chemokines RANTES, MIP-1β, and
eotaxin as well as some growth factors (GM-CSF, G-CSF) are also overproduced by AD-derived PBMC activated by rAβ42.
These results support the involvement of systemic immunity in AD patients. However, our study is an observational one so we
cannot draw a conclusion about its contribution to the pathophysiology of the disease
Genetics of longevity. Data from the studies on Sicilian centenarians
The demographic and social changes of the past decades have determined improvements in public health and
longevity. So, the number of centenarians is increasing as a worldwide phenomenon. Scientists have focused their
attention on centenarians as optimal model to address the biological mechanisms of “successful and unsuccessful
ageing”. They are equipped to reach the extreme limits of human life span and, most importantly, to show
relatively good health, being able to perform their routine daily life and to escape fatal age-related diseases, such
as cardiovascular diseases and cancer. Thus, particular attention has been centered on their genetic background
and immune system. In this review, we report our data gathered for over 10 years in Sicilian centenarians. Based
on results obtained, we suggest longevity as the result of an optimal performance of immune system and an overexpression
of anti-inflammatory sequence variants of immune/inflammatory genes. However, as well known,
genetic, epigenetic, stochastic and environmental factors seem to have a crucial role in ageing and longevity.
Epigenetics is associated with ageing, as demonstrated in many studies. In particular, ageing is associated with a
global loss of methylation state. Thus, the aim of future studies will be to analyze the weight of epigenetic
changes in ageing and longevity
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence
Although the progression of chronic lymphocytic leukemia (CLL) requires the cooperation of the microenvironment, the exact cellular and molecular mechanisms involved are still unclear. We investigated the interleukin (IL)-23 receptor (IL-23R)/IL-23 axis and found that circulating cells from early-stage CLL patients with shorter time-to-treatment, but not of those with a more benign course, expressed a defective form of the IL-23R complex lacking the IL-12R beta 1 chain. However, cells from both patient groups expressed the complete IL-23R complex in tissue infiltrates and could be induced to express the IL-12R. 1 chain when cocultured with activated T cells or CD40L(+) cells. CLL cells activated in vitro in this context produced IL-23, a finding that, together with the presence of IL-23 in CLL lymphoid tissues, suggests the existence of an autocrine/paracrine loop inducing CLL cell proliferation. Interference with the IL-23R/IL-23 axis using an anti-IL-23p19 antibody proved effective in controlling disease onset and expansion in xenografted mice, suggesting potential therapeutic strategies